Novo Nordisk ® 22 results nitiation results nitiation results n PH 1 (US) ssion (HwI) ults (HwoI) results Clinical milestones 1 Q4 2022 Regulatory milestones 1 H1 2023 Phase 2 results ✓ Phase 3 initiation Submission (US/EU/CN) Phase 3 results Phase 3 results Phase 1/2 results ✓ Phase 3 treatment 2 EU submission (HwI) Q4 2021, which is solely for baselining purposes; ce weekly; T2DM:Type 2 Diabetes Mellitus; US: United States; EU: European Union; CN: China; JP: Japan
Download PDF file